These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7034641

  • 1. Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial.
    Wallace RJ, Martin RR, Quinones FJ, Greenberg SB.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):648-52. PubMed ID: 7034641
    [Abstract] [Full Text] [Related]

  • 2. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ, Niefield SL, Waters S, Waters B, Awe RJ, Wiss K, Martin RR, Greenberg SB.
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [Abstract] [Full Text] [Related]

  • 3. Ceforanide (BL-S786) in the treatment of community-acquired bacterial pneumonia.
    Wallace RJ, Martin RR, Greenberg SB.
    Infection; 1979 Feb; 7(4):176-9. PubMed ID: 315929
    [Abstract] [Full Text] [Related]

  • 4. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia.
    Belliveau P, Hickingbotham N, Maderazo EG, Mazens-Sullivan M, Robinson A.
    Pharmacotherapy; 1993 Feb; 13(4):396-401. PubMed ID: 8361868
    [Abstract] [Full Text] [Related]

  • 5. Cefamandole treatment of pulmonary infection caused by gram-negative rods.
    Mandell GL.
    Scand J Infect Dis Suppl; 1980 Feb; suppl 25():107-11. PubMed ID: 7010535
    [Abstract] [Full Text] [Related]

  • 6. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [Abstract] [Full Text] [Related]

  • 7. Clinical and laboratory evaluation of cefamandole in the therapy of Haemophilus spp. Bronchopulmonary infections.
    Delgado DG, Brau CJ, Cobbs CG, Dismukes WE.
    Antimicrob Agents Chemother; 1979 Jun; 15(6):807-12. PubMed ID: 383011
    [Abstract] [Full Text] [Related]

  • 8. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [Abstract] [Full Text] [Related]

  • 9. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
    Lee FH, Pfeffer M, Van Harken DR, Smyth RD, Hottendorf GH.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
    [Abstract] [Full Text] [Related]

  • 10. Ceforanide compared with cefazolin in skin and soft tissue infections.
    Parish LC, Witkowski JA.
    Cutis; 1984 Mar; 33(3):313-5, 319. PubMed ID: 6373165
    [Abstract] [Full Text] [Related]

  • 11. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.
    Lee FH, Smyth RD, Van Harken DR.
    Antimicrob Agents Chemother; 1981 Apr; 19(4):625-7. PubMed ID: 7247385
    [Abstract] [Full Text] [Related]

  • 12. Clinical and laboratory evaluation of cefamandole in infants and children.
    Rodriguez WJ, Ross S, Khan WN, Goldenberg R.
    J Infect Dis; 1978 May; 137 Suppl():S150-S154. PubMed ID: 306402
    [Abstract] [Full Text] [Related]

  • 13. Cefamandole failure in ampicillin-resistant Haemophilus influenzae b pneumonia.
    Markham RE, Insel RA, Betts RF, Robertson RG.
    South Med J; 1981 Feb; 74(2):147-50. PubMed ID: 6970414
    [Abstract] [Full Text] [Related]

  • 14. Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.
    Williams D, Perri M, Zervos MJ.
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):293-8. PubMed ID: 8070432
    [Abstract] [Full Text] [Related]

  • 15. Cefamandole vs. procaine penicillin for treatment of pneumonia due to Streptococcus pneumoniae: a random trial.
    Plaut ME, Perlino CA.
    J Infect Dis; 1978 May; 137 Suppl():S133-S138. PubMed ID: 349092
    [Abstract] [Full Text] [Related]

  • 16. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Campoli-Richards DM, Lackner TE, Monk JP.
    Drugs; 1987 Oct; 34(4):411-37. PubMed ID: 3315624
    [Abstract] [Full Text] [Related]

  • 17. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers.
    Greenman RL, Arcey SM, Gutterman DA, Zweig RM.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):16-9. PubMed ID: 6703681
    [Abstract] [Full Text] [Related]

  • 18. Clinical and laboratory investigation of cefamandole therapy of infections in infants and children.
    Azimi PH.
    J Infect Dis; 1978 May; 137 Suppl():S155-S160. PubMed ID: 349094
    [Abstract] [Full Text] [Related]

  • 19. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
    Geckler RW, McCormack GD, Goodman JS.
    Rev Infect Dis; 1984 May; 6 Suppl 4():S847-52. PubMed ID: 6395275
    [Abstract] [Full Text] [Related]

  • 20. In vitro and clinical evaluation of ceforanide.
    Lefrock JL, Holloway W, Carr BB, Schell RF.
    Am J Med Sci; 1984 May; 287(2):21-5. PubMed ID: 6711584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.